We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Modified Protein Structures Analyzed by Selected Reaction Monitoring

By LabMedica International staff writers
Posted on 07 Oct 2014
Print article
Agilent Technologies\' Cary Eclipse Fluorescence Spectrophotometer
The Cary Eclipse Fluorescence Spectrophotometer (Photo courtesy of AGILENT)
A novel method has been developed to measure the majority of structurally modified proteins in any biological sample, which can contain thousands of different proteins.

Although there is a series of techniques to study structurally modified proteins, such as X-ray crystallography, nuclear magnetic resonance spectroscopy and other spectroscopic techniques, they cannot be used to analyze complex biological samples.

Scientists at the Swiss Federal Institute of Technology, (ETH; Zurich, Switzerland) combined an older technique and a modern approach from proteome studies. The established digestive enzymes such as proteinase K were added to the sample, which cut the proteins depending on their structure into smaller pieces known as peptides. The fragments can then be measured using a technique called Selected Reaction Monitoring (SRM). This method enables many different peptides to be sought specifically and their quantities measured. Based on the peptides found, proteins that were originally present in the sample can be determined and quantified.

The team used various techniques in their study where aliquots of the sample were subjected to the thioflavin T (ThT) binding assay, to circular dichroism, and Fourier transform infrared spectroscopy measurements and were imaged by transmission electron microscopy (TEM) to confirm the formation of amyloid-like fibrils. For the ThT assay fluorescence emissions were recorded at 484 nm on a Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies Inc.; Loveland, CO, USA). Fourier transform infrared spectroscopy measurements were conducted on a 1,720× spectrometer (PerkinElmer Life Sciences; Waltham, MA, USA).

The investigators devised a test to specifically measure the normal and altered versions of the protein alpha-synuclein in complex, unpurified samples such as blood or cerebrospinal fluid. Alpha-synuclein is thought to cause Parkinson's when its structure is modified. The pathological structural variety congregates with its own kind to form amyloid fibrils, which harm neuronal cells. With the aid of the test, the scientists managed to measure the exact amount of pathogenic and non-pathogenic alpha-synuclein directly in a complex sample. The test also yielded information on the structure of the protein.

Paola Picotti, PhD, a professor of protein network biology and senior author of the study, said, “As the new method enables us to measure both structures of the alpha-synuclein protein in a large variety of samples, it might be possible to use this to develop new biomarkers for this disease in the future. The number of amyloidosis, diseases that develop due to changes in protein structures, increases every year.” The study was published on September 14, 2014, in the journal Nature Biotechnology.

Related Links:

Swiss Federal Institute of Technology
Agilent Technologies
PerkinElmer Life Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.